{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T22:48:15Z","timestamp":1756075695394},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1016\/j.recesp.2011.04.016","type":"journal-article","created":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T14:57:00Z","timestamp":1309532220000},"page":"667-673","source":"Crossref","is-referenced-by-count":13,"title":["Efectos a largo plazo (5 a\u00f1os) de bosent\u00e1n en pacientes con hipertensi\u00f3n arterial pulmonar"],"prefix":"10.1016","volume":"64","author":[{"given":"Patricia","family":"Avellana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Sufrate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"G\u00f3mez-Bueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Garc\u00eda-Cos\u00edo Carmena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Garc\u00eda-Pav\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Guti\u00e9rrez Landaluce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"P\u00e9rez Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Alonso-Pulp\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.recesp.2011.04.016_bib0005","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.recesp.2011.04.016_bib0010","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/eurheartj\/ehp297","volume":"30","author":"Gali\u00e8","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.recesp.2011.04.016_bib0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.recesp.2011.04.016_bib0020","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.recesp.2011.04.016_bib0025","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.recesp.2011.04.016_bib0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1183\/09031936.05.00054804","article-title":"Survival with first-line bosentan in patients with primary pulmonary hypertension","volume":"25","author":"McLaughlin","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.recesp.2011.04.016_bib0035","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/ard.2007.079921","article-title":"Long-term effects of bosent\u00e1n on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases","volume":"67","author":"Denton","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.recesp.2011.04.016_bib0040","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jacc.2008.08.059","article-title":"Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFIT: a randomized, placebo-controlled trial","volume":"52","author":"Ja\u00efs","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.recesp.2011.04.016_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.recesp.2011.04.016_bib0050","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","article-title":"Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial","volume":"371","author":"Gali\u00e8","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.recesp.2011.04.016_bib0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/eurheartj\/ehi728","article-title":"Long term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension","volume":"27","author":"Provencher","year":"2006","journal-title":"Eur Heart J"},{"issue":"Suppl 3","key":"10.1016\/j.recesp.2011.04.016_bib0060","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2362.2006.01688.x","article-title":"Survival in patients with pulmonary arterial hypertension treated with first-line bosentan","volume":"36","author":"McLaughlin","year":"2006","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.recesp.2011.04.016_bib0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/hrt.2006.100388","article-title":"Long term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study","volume":"93","author":"Apostolopoulou","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.recesp.2011.04.016_bib0070","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.ahj.2007.06.003","article-title":"Long-term effect of bosentan in adults versus children with pulmonary arterial hypertension associated with systemic-to-pulmonary shunt: does the beneficial effect persist?","volume":"154","author":"Van Loon","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.recesp.2011.04.016_bib0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0300-8932(09)72103-7","article-title":"Tratamiento a largo plazo con bosent\u00e1n de cardiopat\u00edas cong\u00e9nitas complejas en situaci\u00f3n de Eisenmenger","volume":"62","author":"D\u00edaz-Caraballo","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.recesp.2011.04.016_bib0080","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0735-1097(03)00463-7","article-title":"Beraprost therapy for pulmonary arterial hipertensi\u00f3n","volume":"41","author":"Barst","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.recesp.2011.04.016_bib0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.109.883876","article-title":"Improved survival among patients with Eisenmenger syndrome receiving advanced therapy for pulmonary arterial hypertension","volume":"121","author":"Dimopoulos","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.recesp.2011.04.016_bib0090","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1183\/09031936.04.00051104","article-title":"Combination therapy with bosent\u00e1n and sildenafil in idiopathic pulmonary arterial hipertensi\u00f3n","volume":"24","author":"Hoeper","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.recesp.2011.04.016_bib0095","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1161\/01.CIR.102.8.865","article-title":"Brain Natriuretic peptide as a prognostic indicator in patients with primary pulmonar hypertension","volume":"102","author":"Nagaya","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.recesp.2011.04.016_bib0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0300-8932(10)70120-2","article-title":"Evaluaci\u00f3n diagn\u00f3stica y pron\u00f3stica actual de la hipertensi\u00f3n pulmonar","volume":"63","author":"Escribano Subias","year":"2010","journal-title":"Rev Esp Cardiol"}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893211004829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300893211004829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T19:20:46Z","timestamp":1543692046000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300893211004829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S0300893211004829"],"URL":"https:\/\/doi.org\/10.1016\/j.recesp.2011.04.016","relation":{},"ISSN":["0300-8932"],"issn-type":[{"value":"0300-8932","type":"print"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}